Start / PharmaTalkRadio / Case study life of a chief medical officer pre and post ipo

PharmaTalkRadio

Case Study: Life of a Chief Medical Officer Pre and Post IPO

32 min • 2 december 2019

In this talk, first recorded at the 7th annual Chief Medical Officer Summit, Dr Tal Zaks, Chief Medical Officer, Moderna Therapeutics shares his experience and lessons learned through one of the biggest transitions a Chief Medical Officer can make in biotech: Expanding the role of the CMO to meet the requirements of a public companyInsights into the experienceManaging growthWhat role does the CMO have in articulating the data of clinical trials What role does the CMO have in business development opportunitiesWhat are the personal implications of being a CMO in a publicly traded companyLessons learned Learn more at theconferenceforum.org

Senaste avsnitt

Stanford's Dr Crystal Mackall on the Evolution of and Future Directions in Cell Therapy

14 augusti | 29 min

De-Risking Clinical Operations by Taking a Scaffolding Approach to Outsourcing

12 augusti | 28 min

Balancing Between Concentration and Volume when Developing Patient-Centric Biologics

12 augusti | 28 min

Directors' Talk DPHARM 2025 - AI Sessions; Part III

25 juli | 6 min

Innovations in Manufacturing to Make CAR-T More Accessible and Affordable

25 juli | 20 min

Podcastbild

00:00 -00:00

Podcastbild

00:00 -00:00